Redhill Biopharma-sp Adr logo

Redhill Biopharma-sp Adr Share Price (NASDAQ: RDHL)

$1.34

-0.03

(-2.19%)

Live

Last updated on

Check the interactive Redhill Biopharma-sp Adr Stock chart to analyse performance

Redhill Biopharma-sp Adr stock performance

as on August 27, 2025 at 1:29 AM IST

  • Today's Low:$1.34
    Today's High:$1.34

    Day's Volatility :0.0%

  • 52 Weeks Low:$1.06
    52 Weeks High:$12.50

    52 Weeks Volatility :91.52%

Redhill Biopharma-sp Adr Stock Returns

PeriodRedhill Biopharma Ltd-sp AdrSector (Health Care)Index (Russel 2000)
3 Months
-27.17%
4.5%
0.0%
6 Months
-68.47%
-7.9%
0.0%
1 Year
-84.1%
-12.3%
0.0%
3 Years
-99.86%
7.0%
-6.9%

Redhill Biopharma Ltd-sp Adr Key Stats

Check Redhill Biopharma-sp Adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.37
Open
$1.34
Today's High
$1.37
Today's Low
$1.34
Market Capitalization
$3.0M
Today's Volume
$32.4K
52 Week High
$12.5
52 Week Low
$1.06
Revenue TTM
$8.0M
EBITDA
$-12.2M
Earnings Per Share (EPS)
$0.0
PE Ratio
0.0
Profit Margin
-102.8%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1708.61%

Stock Returns calculator for Redhill Biopharma-sp Adr Stock including INR - Dollar returns

The Redhill Biopharma-sp Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Redhill Biopharma-sp Adr investment value today

Current value as on today

₹20,407

Returns

₹79,593

(-79.59%)

Returns from Redhill Biopharma-sp Adr Stock

₹84,104 (-84.1%)

Dollar Returns*

₹4,511 (+4.51%)

Indian investors sentiment towards Redhill Biopharma-sp Adr Stock

-27%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Redhill Biopharma-sp Adr Stock from India on INDmoney has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Redhill Biopharma Ltd-sp Adr

  • Name

    Holdings %

  • Citadel Advisors Llc

    0.94%

  • Federation des caisses Desjardins du Quebec

    0.15%

  • GAMMA Investing LLC

    0.09%

  • Rhumbline Advisers

    0.06%

  • Bank of America Corp

    0.01%

Analyst Recommendation on Redhill Biopharma-sp Adr Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Redhill Biopharma-sp Adr(by analysts ranked 0 to 5 stars)

Redhill Biopharma-sp Adr Share Price Target

What analysts predicted

Upside of 1417810.45%

Target:

$19,000.00

Current:

$1.34

Redhill Biopharma-sp Adr share price target is $19,000.00, a slight Upside of 1417810.45% compared to current price of $1.34 as per analysts' prediction.

Redhill Biopharma-sp Adr Stock Insights

  • Price Movement

    In the last 7 days, RDHL stock has moved down by -7.6%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 567.5K → 2.73M (in $), with an average increase of 27.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -1.54M → -2.59M (in $), with an average decrease of 33.9% per quarter
  • RDHL vs HLN (1 yr)

    In the last 1 year, Redhill Biopharma Ltd-sp Adr has experienced a drawdown of -84.1%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 82.1%
  • RDHL vs HLN (3 yr)

    In the last 3 years, Haleon Plc Spon Ads has given 55.2% return, outperforming this stock by 155.1%
  • Price to Sales

    ForRDHL every $1 of sales, investors are willing to pay $0.2, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Redhill Biopharma Ltd-sp Adr Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$8.0M
↑ 23.49%
Net Income
$-8.3M
↓ 134.57%
Net Profit Margin
-102.8%
↓ 469.99%

Redhill Biopharma-sp Adr Technicals Summary

Sell

Neutral

Buy

Redhill Biopharma-sp Adr is currently in a neutral trading position according to technical analysis indicators.

Redhill Biopharma Ltd-sp Adr Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Redhill Biopharma Ltd-sp Adr logo
-17.79%
-68.47%
-84.1%
-99.86%
-99.98%
Haleon Plc Spon Ads logo
-0.31%
-4.73%
-2.03%
59.31%
30.5%
United Therapeutics Corporation logo
2.4%
-14.6%
-11.93%
40.37%
71.69%
Zoetis Inc. logo
2.91%
-7.95%
-14.56%
-1.74%
-2.81%
Neurocrine Biosciences Inc. logo
0.24%
15.65%
-11.98%
27.26%
17.4%

About Redhill Biopharma Ltd-sp Adr

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 that is in Phase 3 clinical trial for the treatment of pulmonary Mycobacterium avium complex disease in adults. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Organization
Redhill Biopharma-sp Adr
Employees
35
CEO
Mr. Dror Ben-Asher
Industry
Health Technology

Key Management of Redhill Biopharma Ltd-sp Adr

NameTitle
Mr. Dror Ben-Asher
Co-Founder, Chairman & CEO
Mr. Razi Ingber
Chief Financial Officer
Mr. Adi Frish
Chief Corporate & Business Development Officer
Mr. Rick D. Scruggs
Chief Commercial Officer & Director
Mr. Gilead Raday MPhil, MSc
Chief Operating Officer
Ms. Alexandra Okmian
Senior Business Development & Investor Relations Manager
Dr. Reza Fathi Ph.D.
Senior Vice President of Research & Development
Mr. Guy Goldberg J.D.
Chief Business Officer
Ms. Patricia Anderson B.Sc. RAC
Senior Vice President of Regulatory Affairs

Important FAQs about investing in RDHL Stock from India :

What is Redhill Biopharma-sp Adr share price today?

Redhill Biopharma-sp Adr share price today is $1.34 as on . Redhill Biopharma-sp Adr share today touched a day high of $1.34 and a low of $1.34.

What is the 52 week high and 52 week low for Redhill Biopharma-sp Adr share?

Redhill Biopharma-sp Adr share touched a 52 week high of $12.50 and a 52 week low of $1.06. Redhill Biopharma-sp Adr stock price today i.e. is trending at $1.34, lower by 89.28% versus the 52 week high.

How to invest in Redhill Biopharma-sp Adr Stock (RDHL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Redhill Biopharma-sp Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Redhill Biopharma-sp Adr Shares that will get you 1.1194 shares as per Redhill Biopharma-sp Adr share price of $1.34 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Redhill Biopharma-sp Adr Stock (RDHL) from India?

Indian investors can start investing in Redhill Biopharma-sp Adr (RDHL) shares with as little as ₹87.639 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.39 in Redhill Biopharma-sp Adr stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Redhill Biopharma-sp Adr share’s latest price of $1.34 as on August 27, 2025 at 1:29 AM IST, you will get 7.4627 shares of Redhill Biopharma-sp Adr. Learn more about fractional shares .

What are the returns that Redhill Biopharma-sp Adr has given to Indian investors in the last 5 years?

Redhill Biopharma-sp Adr stock has given -99.98% share price returns and 18.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?